Cardiac catheterization in patients with end-stage liver disease: Safety and outcomes

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 1, 2011, Pages 45-48

  Pillarisetti, Jayasree ^a   Patel, Pavan ^a   Duthuluru, Sowjanya ^a   Roberts, Jenny ^a   Chen, Warren ^a   Genton, Randall ^a   Wiley, Mark ^a   Candipan, Robert ^a   Tadros, Peter ^a   Gupta, Kamal ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

bleeding risk; cirrhosis; heart catheterization

Indexed keywords

FRESH FROZEN PLASMA; HEMOGLOBIN;

ADULT; ANGIOGRAPHY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; END STAGE LIVER DISEASE; FEMALE; HEART CATHETERIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ACADEMIC MEDICAL CENTERS; AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CATHETERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; END STAGE LIVER DISEASE; EQUIPMENT DESIGN; FEMALE; HEART CATHETERIZATION; HEMOGLOBINS; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; INTERNATIONAL NORMALIZED RATIO; KANSAS; LENGTH OF STAY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 78650647516     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22591     Document Type: Article

References (12)

1. Warnaar N, Lisman T, Porte RJ,. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant 2008; 13: 298-303.
2. Lisman T, Leebeek FW,. Hemostatic alterations in liver disease: A review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007; 24: 250-258.
3. Kujovich JL,. Hemostatic defects in end stage liver disease. Crit Care Clin 2005; 21: 563-587.
4. Trotter JF,. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis 2006; 10: 665-678.
5. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF,. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with endstage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180-1188.
6. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, Flamm S, Davidson CJ, Gheorghiade M,. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006; 98: 178-181.
7. Lim R, Anderson H, Walters MI, et al. Femoral complications and bed rest duration after coronary arteriography. Am J Cardiol 1997; 15: 222-223.
8. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007; 28: 1936-1945.
9. Farouque HM, Tremmel JA, Shabari R, et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 2005; 45: 363-368.
10. Borioni R, Garofalo M, De Paulis R, Albano P, Caprara E, Fratticci L, Chiariello L,. Surgical treatment of femoral artery pseudoaneurysms after cardiac catheterization. Minerva Chir 2008; 63: 277-282.
11. Vaitkus P, Dickens C, McGrath M,. Low bleeding risk from cardiac catheterization in patients with advanced liver disease. Catheter Cardiovasc Interv 2005; 65: 510-512.
12. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, Ports TA, Yeghiazarians Y, Gregoratos G, Boyle AJ,. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol 2009; 103: 742-746.